Medidata Solutions (MDSO) Downgraded to “Hold” at SunTrust Banks

Medidata Solutions (NASDAQ:MDSO) was downgraded by analysts at SunTrust Banks from a “buy” rating to a “hold” rating in a research report issued on Wednesday, The Fly reports.

A number of other equities analysts have also recently weighed in on the stock. William Blair started coverage on shares of Medidata Solutions in a research report on Monday, April 15th. They set an “outperform” rating and a $74.93 price objective for the company. Leerink Swann started coverage on shares of Medidata Solutions in a research report on Wednesday, January 2nd. They set a “market perform” rating and a $70.00 price objective for the company. TheStreet raised shares of Medidata Solutions from a “c+” rating to a “b-” rating in a research report on Friday, March 15th. Piper Jaffray Companies lowered their price objective on shares of Medidata Solutions to $83.00 and set an “overweight” rating for the company in a research report on Friday, January 4th. Finally, BidaskClub raised shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research report on Wednesday, January 30th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $84.07.

Shares of NASDAQ MDSO opened at $87.69 on Wednesday. The company has a market cap of $5.61 billion, a PE ratio of 91.34, a PEG ratio of 5.35 and a beta of 1.35. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.71 and a quick ratio of 2.71. Medidata Solutions has a 1 year low of $60.10 and a 1 year high of $91.70.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings data on Tuesday, February 12th. The company reported $0.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.37 by $0.08. The firm had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $168.08 million. Medidata Solutions had a net margin of 8.17% and a return on equity of 10.03%. The firm’s quarterly revenue was up 18.1% on a year-over-year basis. During the same quarter last year, the company posted $0.41 EPS. On average, sell-side analysts expect that Medidata Solutions will post 0.8 EPS for the current fiscal year.

In other Medidata Solutions news, CFO Rouven Bergmann sold 12,512 shares of the firm’s stock in a transaction that occurred on Wednesday, February 6th. The shares were sold at an average price of $75.00, for a total value of $938,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Daniel Patrick Shannon sold 19,725 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $75.17, for a total transaction of $1,482,728.25. Following the completion of the transaction, the executive vice president now directly owns 70,497 shares of the company’s stock, valued at approximately $5,299,259.49. The disclosure for this sale can be found here. Insiders sold a total of 47,237 shares of company stock valued at $3,568,628 in the last three months. 4.70% of the stock is currently owned by corporate insiders.

Hedge funds have recently modified their holdings of the business. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Medidata Solutions by 127.2% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock valued at $64,000 after purchasing an additional 529 shares in the last quarter. Bronfman E.L. Rothschild L.P. raised its holdings in shares of Medidata Solutions by 26.9% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 1,286 shares of the company’s stock valued at $87,000 after purchasing an additional 273 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in shares of Medidata Solutions in the 4th quarter valued at $90,000. Canton Hathaway LLC acquired a new stake in shares of Medidata Solutions in the 1st quarter valued at $109,000. Finally, Whittier Trust Co. of Nevada Inc. raised its holdings in shares of Medidata Solutions by 1,068.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,558 shares of the company’s stock valued at $172,000 after purchasing an additional 2,339 shares in the last quarter.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Featured Story: How does new data get added to a blockchain?

The Fly

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.